| Trial ID: | L0841 |
| Source ID: | NCT02908152
|
| Associated Drug: |
Curcumin
|
| Title: |
The Effect of Curcumin Supplement on Metabolic Factors and Hepatic Fibrosis in Nonalcoholic Fatty Liver Patients
|
| Acronym: |
--
|
| Status: |
Not recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Type 2 Diabetes;Nonalcoholic Fatty Liver
|
| Interventions: |
Dietary Supplement: curcumin;Dietary Supplement: placebo
|
| Outcome Measures: |
Hepatic steatosisGlucose;HBA1C;ALT;AST
|
| Sponsor/Collaborators: |
National Nutrition and Food Technology Institute
|
| Gender: |
All
|
| Age: |
30 Years65 Years
|
| Phases: |
Phase 2/Phase 3
|
| Enrollment: |
50
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
|
| Start Date: |
05/09/2016
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
12 December 2020
|
| Locations: |
Iran, Islamic Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT02908152
|
